Dose-dependent phosphoproteomic profiling of Panc-1 cells upon treatment with gefitinib

ABSTRACT: Panc-1 cells were treated with 6 different concentration of gefitinib (0, 0.1, 1, 10, 100, 1000 nM) and analyzed by phosphoproteomics using a highly selective phosphopeptide enrichment method based on aliphatic hydroxy acid-modified metal oxide chromatography (HAMMOC) coupled with nanoLC-MS/MS.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Yasushi Ishihama 

PROVIDER: PXD006307 | JPOST Repository | Wed Apr 18 00:00:00 BST 2018

REPOSITORIES: jPOST